0 Valutazioni

ID

13238

Descrizione

A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML; ODM derived from: https://clinicaltrials.gov/show/NCT02040506

collegamento

https://clinicaltrials.gov/show/NCT02040506

Keywords

  1. 25/01/16 25/01/16 -
Titolare del copyright

CC BY-NC 3.0

Caricato su

25 gennaio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Eligibility Acute Myelogenous Leukemia NCT02040506

    Eligibility Acute Myelogenous Leukemia NCT02040506

    Inclusion Criteria
    Descrizione

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    relapsed or treatment-refractory aml
    Descrizione

    AML

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0023467 (Leukemia, Myelocytic, Acute)
    SNOMED
    17788007
    eastern cooperative oncology group status 0-2
    Descrizione

    ECOG

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C1520224 (ECOG performance status)
    SNOMED
    423740007
    life expectancy of at least 12 weeks
    Descrizione

    life expectancy

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0023671 (Life Expectancy)
    adequate baseline renal and hepatic function
    Descrizione

    renal and hepatic function

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0232804 (Renal function)
    SNOMED
    11953005
    LOINC
    LP31398-8
    UMLS CUI [2]
    C0232741 (Liver function)
    SNOMED
    79036002
    LOINC
    LP31397-0
    measurable disease (eg, peripheral blasts greater than 5%)
    Descrizione

    measurable disease

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C1513041 (Measurable Disease)
    Exclusion Criteria
    Descrizione

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    chronic myelogenous leukemia in blast crisis
    Descrizione

    CML

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0023474 (Leukemia, Myeloid, Chronic-Phase)
    SNOMED
    413847001
    monoclonal therapy within 4 weeks, or chemotherapy or radiotherapy within 2 weeks
    Descrizione

    monoclonal therapy or chemotherapy or radiotherapy

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0392920 (Chemotherapy Regimen)
    SNOMED
    716872004
    UMLS CUI [2]
    C1522449 (Therapeutic radiology procedure)
    SNOMED
    53438000
    LOINC
    LA4351-8
    UMLS CUI [3]
    C0279694 (Monoclonal Antibody Therapy)
    unresolved acute toxicity from prior anti-cancer therapy
    Descrizione

    toxicity

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0013221 (Drug toxicity)
    SNOMED
    7895008
    prior allogeneic stem cell transplant and active graft-versus-host disease requiring systemic immunosuppressive therapy within 15 days prior to screening
    Descrizione

    stem cell transplant and graft-versus-host disease

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C1504389 (Stem cell transplant)
    UMLS CUI [2]
    C0018133 (Graft-vs-Host Disease)
    SNOMED
    234646005
    history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
    Descrizione

    allergic or anaphylactic reactions to monoclonal antibody therapy

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517 (Hypersensitivity)
    SNOMED
    421961002
    LOINC
    LP20697-6
    UMLS CUI [1,2]
    C0279694 (Monoclonal Antibody Therapy)
    known current leptomeningeal or central nervous system (cns) involvement of leukemia
    Descrizione

    cns leukemia

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C1332884 (Central nervous system leukaemia)

    Similar models

    Eligibility Acute Myelogenous Leukemia NCT02040506

    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    C1512693 (UMLS CUI)
    AML
    Item
    relapsed or treatment-refractory aml
    boolean
    C0023467 (UMLS CUI [1])
    ECOG
    Item
    eastern cooperative oncology group status 0-2
    boolean
    C1520224 (UMLS CUI [1])
    life expectancy
    Item
    life expectancy of at least 12 weeks
    boolean
    C0023671 (UMLS CUI [1])
    renal and hepatic function
    Item
    adequate baseline renal and hepatic function
    boolean
    C0232804 (UMLS CUI [1])
    C0232741 (UMLS CUI [2])
    measurable disease
    Item
    measurable disease (eg, peripheral blasts greater than 5%)
    boolean
    C1513041 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    CML
    Item
    chronic myelogenous leukemia in blast crisis
    boolean
    C0023474 (UMLS CUI [1])
    monoclonal therapy or chemotherapy or radiotherapy
    Item
    monoclonal therapy within 4 weeks, or chemotherapy or radiotherapy within 2 weeks
    boolean
    C0392920 (UMLS CUI [1])
    C1522449 (UMLS CUI [2])
    C0279694 (UMLS CUI [3])
    toxicity
    Item
    unresolved acute toxicity from prior anti-cancer therapy
    boolean
    C0013221 (UMLS CUI [1])
    stem cell transplant and graft-versus-host disease
    Item
    prior allogeneic stem cell transplant and active graft-versus-host disease requiring systemic immunosuppressive therapy within 15 days prior to screening
    boolean
    C1504389 (UMLS CUI [1])
    C0018133 (UMLS CUI [2])
    allergic or anaphylactic reactions to monoclonal antibody therapy
    Item
    history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
    boolean
    C0020517 (UMLS CUI [1,1])
    C0279694 (UMLS CUI [1,2])
    cns leukemia
    Item
    known current leptomeningeal or central nervous system (cns) involvement of leukemia
    boolean
    C1332884 (UMLS CUI [1])

    Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

    I campi contrassegnati da * sono obbligatori.

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial